Bibliography

Export 9 results:

Filters: Keyword is Serologic Tests [Clear All Filters]

2013

Servant-Delmas A, Chuteau C, Lefort C, Piquet Y, Chevaleyre S, Betbeze V, et al. Two cases of transfusion-transmitted hepatitis B virus (HBV) infection in a low-endemic country before implementation of HBV nucleic acid testing. Transfusion// Transfusion. 2013;53(2):291-6.

2012

Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM. HTLV-1 in solid-organ transplantation: current challenges and future management strategies. Transplantation// Transplantation. 2012;94(11):1075-84.

2004

Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol. 2004;11(1):26-32.

1998

Delmonico FL, Snydman DR. Organ donor screening for infectious diseases: review of practice and implications for transplantation. Transplantation. 1998;65(5):603-10.

1997

Hoft RH, Pflugfelder SC, Forster RK, Ullman S, Polack FM, Schiff ER. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea. 1997;16(2):132-7.

1996

Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334(26):1685-90.

1990

Morris A, Strickett MG, Barratt-Boyes BG. Use of aortic valve allografts from hepatitis B surface antigen-positive donors. Ann Thorac Surg. 1990;49(5):802-5.

1988

Holland EJ, Bennett SR, Brannian R, Osborne JC, Goeken JA, Krachmer JH. The risk of cytomegalovirus transmission by penetrating keratoplasty. Am J Ophthalmol. 1988;105(4):357-60.

Grundy JE, Lui SF, Super M, Berry NJ, Sweny P, Fernando ON, et al. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet. 1988;2(8603):132-5.